Friday, July 29, 2022 1:25:44 AM
What this is about is collateral on the $165k note. The note is also not convertible into shares until after 1 year.
Basically, there is an investor that believes enough to give them $165k and wait a year but just in case the company (and the stock) is not performing as anticipated after that year they have created an additional SPA/Warrant that allows them to be issued additional shares to make up the difference in the event they don't hit targets. It's a fail safe for doing the note and having to ride out for a year.
The 8k should have been worded a bit different, IMO. It should have basically said: "We entered into a note for $165k from an investor. Convertible in July 2023. To further guarantee $165k investment, the Company has agreed to collateralize the note with a warrant to purchase an additional 1.5 bil shares if at the July 2023 time of conversion, the Company has not met the investor's expectations.
In the end, nothing here to be concerned with for a year. No company can issue shares or notes or warrants and they immediately hit the market. There are regulations that restrict them for a year. Such as rule 144.
Furthermore, anytime you hear people say, "the POS CEO is diluting on us". No CEO can just suddenly do that. It is the result of something that had to have occurred at least a year earlier. In most cases it is really just retail traders dumping on you and blaming the company.
Regardless, again, nothing here for at least a year to be concerned with.
Recent BOMO News
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 05/08/2024 12:50:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 08:11:11 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM